Yangon Cuts Palm Oil Purchase Limit to 4.1kg per Order New Policy Effective August 4
Yangon’s Household Palm Oil Distribution Committee has announced a new policy: starting August 4, households can only buy up to 2.5 viss (about 4.1 kg) of edible palm oil per order—down from the previous limit of 2.75 viss (4.5 kg) per month. The move aims to ensure fair access for families across all 44 townships via home delivery.
Prices will be set weekly, reflecting wholesale guidance and delivery costs. No advance payment is needed; consumers can pay when the oil is delivered, though shipments may arrive up to three days after ordering.
To streamline service, 14 districts and 44 townships have established call centers, taking orders Monday to Friday from 9am to 4pm. Last week’s wholesale benchmark price was set at 6,130 kyat per viss.
The committee emphasizes the policy’s goal is to make palm oil more accessible and manageable for all Yangon families amid ongoing supply pressures.
2026-08-11
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
关于进一步规范化学品信息发布、加强全球管制目录宣导的公告 Announcement on Further Standardizing the Release of Chemical Information and Strengthening Public Awareness of Global Control Lists
-
Pesticide Market in Limbo: Prices Plunge Amid Weak Demand and Overcapacity—Only a Few Hold Firm
-
Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
-
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
FDA Warning Letters Put GMP Back in Focus
-
A Fake Email Drains RMB 12 Million: Asia’s Waterproof Giant’s Overseas ‘Payment Heist’ Exposes the Fatal Blind Spot of Chinese Corporate Globalization
Recommend Reading
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
Global Butadiene Market Faces Heavy Headwinds as Supply Surge Outpaces Demand
-
EPA Clears Backlog of Refinery Biofuel Waivers, Sparking Fears for Ethanol Demand
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
DMF Inventory Remains High, Prices Stay Stable
-
Applications and Safety of Sodium Dichromate
-
Polyethylene Weakens with Fluctuations, Trading Remains Light Before the Chinese New Year
-
Notice of 2026 Chinese New Year Holiday
-
Crude oil remains in negative territory, another round of retail fuel price cuts in China